C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 413/10 (2006.01) A61K 31/4245 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2602624
The present invention provides (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2- cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4- yl]methyl}-1H-benzimidazole-7-carboxylate represented by the formula: which has superior properties as a pharmaceutical agent, a salt thereof, a crystal thereof, a pharmaceutical agent containing the compound, and the like.
L'invention se réfère au composé (5-méthyl-2-oxo-1,3-dioxol-4-yl)méthyl 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphényl-4-yl]méthyl}-1H-benzimidazole-7-carboxylate représenté par la formule (1), qui possède des propriétés supérieures comme agent pharmaceutique, à un sel de ce composé, à un cristal de celui-ci, à un agent pharmaceutique contenant ledit composé et analogue.
Ban Junko
Kuroita Takanobu
Ojima Mami
Fetherstonhaugh & Co.
Takeda Pharmaceutical Company Limited
LandOfFree
Benzimidazole derivative and use as angiotensin ii antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivative and use as angiotensin ii antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivative and use as angiotensin ii antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1626422